M&A Deal Summary |
|
|---|---|
| Date | 2024-07-23 |
| Target | Trukera Medical |
| Sector | Medical Products |
| Buyer(s) | Bausch & Lomb |
| Sellers(s) |
Accelmed
CRG |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1853 |
| Sector | Medical Products |
| Revenue | 3.3B USD (2013) |
Bausch & Lomb is a manufacturer of ophthalmic products.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 8 |
| Sector (Medical Products) | 5 of 6 |
| Type (Add-on Acquisition) | 5 of 6 |
| State (Texas) | 1 of 1 |
| Country (United States) | 4 of 5 |
| Year (2024) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-30 |
Xiidra
Basel, Switzerland XIIDRA (lifitegrast ophthalmic solution) 5% is a prescription eye drop used to treat the signs and symptoms of dry eye disease. Xiidra is based in Basel, Switzerland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-12-11 |
Elios Vision
Los Angeles, California, United States Elios Vision is a developer of the ELIOS™ procedure, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser. Elios Vision was founded in 2019 and is based in Los Angeles, California. |
Buy | - |
Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues between $20 and $70 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in Miami, Florida.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector (Medical Products) | 4 of 4 |
| Type (Add-on Acquisition) | 3 of 3 |
| State (Texas) | 1 of 1 |
| Country (United States) | 4 of 4 |
| Year (2024) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-07-01 |
EndoGastric Solutions
Redmond, Washington, United States EndoGastric Solutions is a medical device company focused on endoluminal reconstructive gastric procedures, focused on treating upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and obesity. EndoGastric Solutions was formed in 2003 and is based in Redmond, Washington. |
Sell | $105M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-10-01 |
Bioventus - Advanced Rehabilitation Business
United States Bioventus' Advanced Rehabilitation Business is a provider of medical products critical for helping patients with stroke and other neuromuscular conditions in their rehabilitation journey. |
Buy | $45M |
CRG is a healthcare focused investment firm focused on growth capital to commercial-stage public and private companies. CRG looks to commit $20 to $300 million that are developing next-generation healthcare products, technologies and services that address significant and substantial unmet medical needs. Specific areas of interest include biopharmaceuticals, specialty pharmaceuticals, medical devices, drug delivery, animal health, tools and diagnostics, and healthcare services. CRG was formed in 2003 and is headquartered in Houston, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector (Medical Products) | 1 of 1 |
| Type (Add-on Acquisition) | 2 of 2 |
| State (Texas) | 1 of 1 |
| Country (United States) | 3 of 3 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-04-18 |
Sanara MedTech
Fort Worth, Texas, United States Sanara MedTech is an entity which markets and distributes wound and skin care products and is seeking to offer wound care and dermatology virtual consultation services via telemedicine to physicians, hospitals, clinics, and all post-acute care settings. Sanara's products are primarily sold in the North American advanced wound care and surgical tissue repair markets. Sanara MedTech was founded in 2001 and is based in Fort Worth, Texas. |
Buy | - |
